Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing | Zendy

Ling Cui | Zendy; Pamela Schroeder | Zendy; Paul Sack | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing

Author(s) -

Ling Cui,

Pamela Schroeder,

Paul Sack

Publication year - 2020

Publication title -

clinical diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.931

H-Index - 37

eISSN - 1945-4953

pISSN - 0891-8929

DOI - 10.2337/cd20-0054

Subject(s) - medicine , glycemic , dosing , insulin , basal insulin , diabetes mellitus , intensive care medicine , basal (medicine) , diabetes management , food and drug administration , insulin pen , medical emergency , pharmacology , type 2 diabetes , endocrinology

Several new technologies use computer algorithms to analyze a person's blood glucose response to insulin treatment, calculate the person's next recommended insulin dose, advise the person regarding when to check blood glucose next, and provide alerts regarding glucose control for the individual patient or across a hospital system. This article reviews U.S. Food and Drug Administration (FDA)-approved products designed to help manage insulin dosing for inpatients, as well as those available to provide people with insulin-requiring diabetes support in making adjustments to their basal and/or mealtime insulin doses. Many of these products have a provider interface that allows for remote monitoring of patients' glucose readings and insulin doses. By alleviating some of the burdens of insulin initiation and dose adjustment, these products may facilitate improved glycemic management and patient outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research